title: Rosacea-like eruption due to topical pimecrolimus.
abstract: Topical calcineurin inhibitors have been used outside their approved indications for a number of conditions, including topical steroid-induced rosacea. However, tacrolimus ointment itself has been reported to trigger rosacea in a small number of cases. We report a case of a rosacea-like eruption in a 39-year-old woman occurring after the use of pimecrolimus cream for 12 months for atopic dermatitis. Withdrawal of pimecrolimus combined with treatment with oral lymecycline, topical metronidazole, and an emollient resulted in resolution of the eruption. There have been 5 previously reported cases of a topical pimecrolimus-induced rosacea-like eruption suggesting that this rare side-effect may be a class effect of all topical calcineurin inhibitors. Dermatologists prescribing these drugs should be aware of this uncommon complication and may wish to warn patients of its occurrence as a potential side-effect when using topical calcineurin inhibitors in facial skin in adults.
authors: Medical Research Council Lifecourse Epidemiology Unit - University of Southampton.
authors: S
authors: S
authors: El-Heis
authors: D A
authors: DA
authors: Buckley
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005148:Facial Dermatoses / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D006801:Humans; D019696:Peptidylprolyl Isomerase / Q000037:antagonists & inhibitors; D012393:Rosacea / Q000139:chemically induced* / Q000175:diagnosis; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D003879:Dermatologic Agents; C117268:pimecrolimus; D019696:Peptidylprolyl Isomerase; D016559:Tacrolimus